Literature DB >> 28823941

Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.

Wendy A Dailey1, Kimberly A Drenser2, Sui Chien Wong1, Mei Cheng1, Joseph Vercellone1, Kevin K Roumayah1, Erin V Feeney1, Mrinalini Deshpande3, Alvaro E Guzman3, Michael Trese2, Kenneth P Mitton4.   

Abstract

Treatment of a mouse model of oxygen-induced retinopathy (OIR) with recombinant human Norrin (Norrie Disease Protein, gene: NDP) accelerates regrowth of the microvasculature into central ischemic regions of the neural retina, which are generated after treatment with 75% oxygen. While this reduces the average duration and severity of ischemia overall, we do not know if this accelerated recovery of the microvasculature results in any significant survival of retinal ganglion cells (RGCs). The purpose of this study was to investigate ganglion cell survival with and without the intravitreal injection of Norrin in the murine model of oxygen induced retinopathy (OIR), using two strains of mice: C57BL/6J and Thy1-YFP mice. Intravitreal injections of Norrin or vehicle were done after five days of exposure to 75% oxygen from ages P7 to P12. The C57BL/J mice were followed by Spectral-Domain Optical Coherence Tomography (SD-OCT), and the average nerve fiber layer (NFL) and inner-plexiform layer (IPL) thicknesses were measured at twenty-four locations per retina at P42. Additionally, some C57BL/J retinas were flat mounted and immunostained for the RGC marker, Brn3a, to compare the population density of surviving retinal ganglion cells. Using homozygous Thy1-YFP mice, single intrinsically fluorescent RGCs were imaged in live animals with a Micron-III imaging system at ages P21, 28 and P42. The relative percentage of YFP-fluorescent RGCs with dendritic arbors were compared. At age P42, the NFL was thicker in Norrin-injected OIR eyes, 14.4 μm, compared to Vehicle-injected OIR eyes, 13.3 μm (p = 0.01). In the superior retina, the average thickness of the IPL was greater in Norrin-injected OIR eyes, 37.7 μm, compared to Vehicle-injected OIR eyes, 34.6 μm (p = 0.04). Retinas from Norrin injected OIR mice had significantly more surviving RGCs (p = 0.03) than vehicle-injected mice. Based upon NFL thickness and counts of RGCs, we conclude that Norrin treatment, early in the ischemic phase, increased the relative population density of surviving RGCs in the central retinas of OIR mice.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ganglion cell; Neovascular; Nerve fiber layer; Norrin; Optical Coherence Tomography; Oxygen induced retinopathy; Retinal ischemia

Mesh:

Substances:

Year:  2017        PMID: 28823941      PMCID: PMC5669624          DOI: 10.1016/j.exer.2017.08.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  44 in total

1.  Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.

Authors:  G S Robinson; M Ju; S C Shih; X Xu; G McMahon; R B Caldwell; L E Smith
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

Review 2.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

3.  Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

Authors:  Robert L Avery; Joel Pearlman; Dante J Pieramici; Melvin D Rabena; Alessandro A Castellarin; Ma'an A Nasir; Matthew J Giust; Robert Wendel; Arun Patel
Journal:  Ophthalmology       Date:  2006-10       Impact factor: 12.079

4.  Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.

Authors:  J Hanhart; L Tiosano; E Averbukh; E Banin; I Hemo; I Chowers
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

Review 5.  The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.

Authors:  Xin Ye; Yanshu Wang; Jeremy Nathans
Journal:  Trends Mol Med       Date:  2010-08-03       Impact factor: 11.951

6.  Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.

Authors:  Liya Wang; Pingling Shi; Zhongzhong Xu; Jing Li; Yanting Xie; Kenneth Mitton; Kimberly Drenser; Qi Yan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-27       Impact factor: 4.799

7.  Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice.

Authors:  Andreas Ohlmann; Roswitha Seitz; Barbara Braunger; David Seitz; Michael R Bösl; Ernst R Tamm
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

8.  Multi-functional norrin is a ligand for the LGR4 receptor.

Authors:  Cheng Deng; Pradeep Reddy; Yuan Cheng; Ching-Wei Luo; Chih-Lun Hsiao; Aaron J W Hsueh
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

9.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

10.  Comparison of the effect of unilateral intravitreal bevacizumab and ranibizumab injection on diabetic macular edema of the fellow eye.

Authors:  Berker Bakbak; Banu Turgut Ozturk; Saban Gonul; Mevlut Yilmaz; Sansal Gedik
Journal:  J Ocul Pharmacol Ther       Date:  2013-07-13       Impact factor: 2.671

View more
  9 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Role of the Endothelium in Neonatal Diseases.

Authors:  Olachi J Mezu-Ndubuisi; Akhil Maheshwari
Journal:  Newborn (Clarksville)       Date:  2022-03-31

Review 3.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

4.  Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.

Authors:  Mónica Díaz-Coránguez; Cheng-Mao Lin; Stefan Liebner; David A Antonetti
Journal:  J Biol Chem       Date:  2020-02-21       Impact factor: 5.157

5.  Ocular coherence tomography image data of the retinal laminar structure in a mouse model of oxygen-induced retinopathy.

Authors:  Wendy A Dailey; Kimberly A Drenser; Sui Chien Wong; Mei Cheng; Joseph Vercellone; Kevin K Roumayah; Erin V Feeney; Mrinalini Deshpande; Alvaro E Guzman; Michael Trese; Kenneth P Mitton
Journal:  Data Brief       Date:  2017-10-06

6.  The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific.

Authors:  Ning Yang; Brent K Young; Ping Wang; Ning Tian
Journal:  Cells       Date:  2020-03-10       Impact factor: 6.600

7.  Biological Correlations and Confounders for Quantification of Retinal Ganglion Cells by Optical Coherence Tomography Based on Studies of Outbred Mice.

Authors:  Adam Hedberg-Buenz; Kacie J Meyer; Carly J van der Heide; Wenxiang Deng; Kyungmoo Lee; Dana A Soukup; Monica Kettelson; Danielle Pellack; Hannah Mercer; Kai Wang; Mona K Garvin; Michael D Abramoff; Michael G Anderson
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

8.  Dendrobium nobile Lindley and its bibenzyl component moscatilin are able to protect retinal cells from ischemia/hypoxia by dowregulating placental growth factor and upregulating Norrie disease protein.

Authors:  Wen-Haur Chao; Ming-Yi Lai; Hwai-Tzong Pan; Huei-Wen Shiu; Mi-Mi Chen; Hsiao-Ming Chao
Journal:  BMC Complement Altern Med       Date:  2018-06-22       Impact factor: 3.659

9.  Norrin Protects Retinal Ganglion Cells from Excitotoxic Damage via the Induction of Leukemia Inhibitory Factor.

Authors:  Stefan Kassumeh; Stephanie Leopold; Rudolf Fuchshofer; Carina N Thomas; Siegfried G Priglinger; Ernst R Tamm; Andreas Ohlmann
Journal:  Cells       Date:  2020-01-23       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.